gsk716155
Showing 1 - 2 of 2
Diabetes, Type 2 Trial in Lexington (GSK716155, Placebo)
Completed
- Diabetes Mellitus, Type 2
- GSK716155
- Placebo
-
Lexington, KentuckyGSK Investigational Site
Aug 15, 2017
CHF Trial in United Kingdom, United States (GSK716155, Placebo)
Completed
- Heart Failure, Congestive
- GSK716155
- Placebo
-
Savannah, Georgia
- +14 more
Jul 14, 2017